Potential of Cancer Biomarkers : From Discovery to Clinical Application

• Presents the impact of biomarkers on early detection, prognosis, and personalized treatment strategies
• Incudes ethical and regulatory considerations surrounding biomarker use, guiding policymakers and ethicists through the complex terrain of biomarker-driven healthcare decisions
• Highlights the clinical relevance of cancer biomarkers by showcasing real-world case studies and examples of how biomarkers have been utilized to improve cancer diagnosis, personalize treatment plans, and monitor treatment responses

Pranav Kumar Prabhakar is Professor and Head of the Department of Biotechnology, School of Engineering and Technology, Nagaland University, Kohima, India. His research focuses on understanding molecular mechanisms involved in metabolic disorders, particularly diabetes, and on developing strategies for oral insulin delivery using natural products and biotechnology-based approaches. He is actively involved in research, academic mentoring, peer review, and editorial activities within the biomedical and biotechnology fields. His professional interests include translational research, signaling pathways associated with metabolic diseases, and the application of biotechnology to improve therapeutic outcomes. He contributes to scientific and academic initiatives that support advancements in biotechnology and healthcare research.